Elevance Health (0HG8) - Total Assets
Based on the latest financial reports, Elevance Health (0HG8) holds total assets worth $121.49 Billion USD as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Elevance Health - Total Assets Trend (1998–2025)
This chart illustrates how Elevance Health's total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Elevance Health - Asset Composition Analysis
Current Asset Composition (December 2025)
Elevance Health's total assets of $121.49 Billion consist of 20.4% current assets and 79.7% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 7.8% |
| Accounts Receivable | $15.23 Billion | 12.5% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $11.20 Billion | 9.2% |
| Goodwill | $28.34 Billion | 23.3% |
Asset Composition Trend (1998–2025)
This chart illustrates how Elevance Health's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Elevance Health's current assets represent 20.4% of total assets in 2025, an increase from 0.0% in 1998.
- Cash Position: Cash and equivalents constituted 7.8% of total assets in 2025, up from 0.0% in 1998.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 32.0% of total assets, an increase from 0.0% in 1998.
- Asset Diversification: The largest asset category is goodwill at 23.3% of total assets.
Elevance Health Competitors by Total Assets
Key competitors of Elevance Health based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
| No similar companies found. | ||
Elevance Health - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.24 | 1.10 | 1.41 |
| Quick Ratio | 1.24 | 1.10 | 3.74 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $4.77 Billion | $1.92 Billion | $5.38 Billion |
Elevance Health - Advanced Valuation Insights
This section examines the relationship between Elevance Health's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.67 |
| Asset Growth Rate (YoY) | 3.9% |
| Total Assets | $121.49 Billion |
| Market Capitalization | $81.38 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Elevance Health's assets below their book value (0.67x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Elevance Health's assets grew by 3.9% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Elevance Health (1998–2025)
The table below shows the annual total assets of Elevance Health from 1998 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $121.49 Billion | +3.94% |
| 2024-12-31 | $116.89 Billion | +7.31% |
| 2023-12-31 | $108.93 Billion | +6.01% |
| 2022-12-31 | $102.75 Billion | +5.43% |
| 2021-12-31 | $97.46 Billion | +10.40% |
| 2020-12-31 | $88.28 Billion | +12.81% |
| 2019-12-31 | $78.25 Billion | +7.98% |
| 2018-12-31 | $72.47 Billion | +1.41% |
| 2017-12-31 | $71.46 Billion | +7.64% |
| 2016-12-31 | $66.39 Billion | +5.27% |
| 2015-12-31 | $63.06 Billion | +0.21% |
| 2014-12-31 | $62.93 Billion | +4.03% |
| 2013-12-31 | $60.49 Billion | +0.47% |
| 2012-12-31 | $60.21 Billion | +13.05% |
| 2011-12-31 | $53.26 Billion | +3.86% |
| 2010-12-31 | $51.28 Billion | -1.63% |
| 2009-12-31 | $52.13 Billion | +7.69% |
| 2008-12-31 | $48.40 Billion | -7.02% |
| 2007-12-31 | $52.06 Billion | +0.58% |
| 2006-12-31 | $51.76 Billion | +0.69% |
| 2005-12-31 | $51.41 Billion | +26.53% |
| 2004-12-31 | $40.63 Billion | +202.99% |
| 2003-12-31 | $13.41 Billion | +7.79% |
| 2002-12-31 | $12.44 Billion | +96.29% |
| 2001-12-31 | $6.34 Billion | +11.01% |
| 2000-12-31 | $5.71 Billion | +18.53% |
| 1999-12-31 | $4.82 Billion | +10.48% |
| 1998-12-31 | $4.36 Billion | -- |
About Elevance Health
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad… Read more